Objectives:
1. Learn the classes of new drugs active against Gram positive bacteria recently approved by the FDA
2 Learn the history and uses of the Pleuromutilin antibiotics and novel agents in this class that are in the pipeline
3 Understand the specific benefits and limitations of the newest drugs in treating MRSA infections
Session date:
12/19/2016 - 12:00pm to 1:00pm CST
Location:
UCMC
C-400
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Michael David, MD, PhD